Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis
Multi-drug resistance is increasingly becoming a challenge to tuberculosis control programmes globally. Treatment of multi-drug resistance tuberculosis (MDR-TB) includes aminoglycoside antibiotics which are known to cause hearing loss. Ototoxicity monitoring services are often provided to patients u...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Communication Sciences and Disorders
2015
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867613173661564928 |
|---|---|
| access_status_str | Open Access |
| author | Nhokwara, Primrose Tinashe |
| author2 | Rogers, Christine |
| author_browse | Nhokwara, Primrose Tinashe Rogers, Christine |
| author_facet | Rogers, Christine Nhokwara, Primrose Tinashe |
| author_sort | Nhokwara, Primrose Tinashe |
| collection | Thesis |
| description | Multi-drug resistance is increasingly becoming a challenge to tuberculosis control programmes globally. Treatment of multi-drug resistance tuberculosis (MDR-TB) includes aminoglycoside antibiotics which are known to cause hearing loss. Ototoxicity monitoring services are often provided to patients undergoing treatment for MDR-TB for early detection of ototoxic hearing loss to facilitate alerting the patients and relevant medical staff about the presence and progression of any hearing loss. Previously, models of managing patients with MDR-TB required mandatory hospitalization for at least 6 months. This made it relatively easy to monitor the hearing status of patients during their stay in the hospital. However, with recent introduction of policy guidelines that support management of patients with MDR-TB on an outpatients basis, ototoxicity monitoring for these patients will need to be reorganized to align with the new policy guidelines. The extent of the uptake of these services when patients are accessing them as outpatients is however, unknown. This study therefore aimed to describe the patterns of utilisation and explore the barriers and factors that facilitate the use of ototoxicity monitoring services when provided on an outpatient basis in the Cape Town Metropolitan area, Western Cape, South Africa. |
| format | Thesis |
| id | oai:open.uct.ac.za:11427/15683 |
| institution | University of Cape Town (South Africa) |
| language | eng |
| last_indexed | 2026-06-10T12:31:56.645Z |
| license_str | Not specified — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository |
| publishDate | 2015 |
| publishDateRange | 2015 |
| publishDateSort | 2015 |
| publisher | Division of Communication Sciences and Disorders |
| publisherStr | Division of Communication Sciences and Disorders |
| record_format | dspace |
| source_str | UCTD — University of Cape Town Open Access Repository |
| spelling | oai:open.uct.ac.za:11427/15683 Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis Nhokwara, Primrose Tinashe Rogers, Christine Ramma, Lebogang Audiology adherence exploratory survey MDR-TB ototoxicity monitoring service utilisation tuberculosis Multi-drug resistance is increasingly becoming a challenge to tuberculosis control programmes globally. Treatment of multi-drug resistance tuberculosis (MDR-TB) includes aminoglycoside antibiotics which are known to cause hearing loss. Ototoxicity monitoring services are often provided to patients undergoing treatment for MDR-TB for early detection of ototoxic hearing loss to facilitate alerting the patients and relevant medical staff about the presence and progression of any hearing loss. Previously, models of managing patients with MDR-TB required mandatory hospitalization for at least 6 months. This made it relatively easy to monitor the hearing status of patients during their stay in the hospital. However, with recent introduction of policy guidelines that support management of patients with MDR-TB on an outpatients basis, ototoxicity monitoring for these patients will need to be reorganized to align with the new policy guidelines. The extent of the uptake of these services when patients are accessing them as outpatients is however, unknown. This study therefore aimed to describe the patterns of utilisation and explore the barriers and factors that facilitate the use of ototoxicity monitoring services when provided on an outpatient basis in the Cape Town Metropolitan area, Western Cape, South Africa. 2015-12-08T11:40:20Z 2015-12-08T11:40:20Z 2015 Master Thesis Masters MSc http://hdl.handle.net/11427/15683 eng application/pdf Division of Communication Sciences and Disorders Faculty of Health Sciences University of Cape Town |
| spellingShingle | Audiology adherence exploratory survey MDR-TB ototoxicity monitoring service utilisation tuberculosis Nhokwara, Primrose Tinashe Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis |
| thesis_degree_str | Master's |
| title | Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis |
| title_full | Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis |
| title_fullStr | Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis |
| title_full_unstemmed | Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis |
| title_short | Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis |
| title_sort | factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug resistant tuberculosis |
| topic | Audiology adherence exploratory survey MDR-TB ototoxicity monitoring service utilisation tuberculosis |
| url | http://hdl.handle.net/11427/15683 |
| work_keys_str_mv | AT nhokwaraprimrosetinashe factorsthatinfluencetheutilisationofototoxicitymonitoringservicesforpatientsontreatmentfordrugresistanttuberculosis |